| All news about POINT BIOPHARMA GLOBAL INC. |
|
|
|
|
|
| Analyst Recommendations on POINT BIOPHARMA GLOBAL INC. |
|
|
|
|
|
|
| Sales 2022 |
–
–
–
|
| Net income 2022 |
-96.6 M
–
–
|
| Net Debt 2022 |
–
–
–
|
| P / E ratio 2022 |
-7.31x |
| Yield 2022 |
– |
|
| Capitalization |
701 M
701 M
–
|
| Capi. / Sales 2022 |
– |
| Capi. / Sales 2023 |
74.7x |
| Nbr of Employees |
72 |
| Free-Float |
82.1% |
|
| Chart POINT BIOPHARMA GLOBAL INC. |
|
Duration:
Period:
|
|
|
|
Technical analysis trends POINT BIOPHARMA GLOBAL INC.
|
Short Term |
Mid-Term |
Long Term |
| Trends |
Neutral |
Neutral |
Neutral |
Income Statement Evolution
|
|
| Mean consensus |
BUY |
| Number of Analysts |
4 |
| Last Close Price |
$ 7.78 |
| Average target price |
$ 19.00 |
| Spread / Average Target |
144% |
|
.
Related
